Eclipsebio Acquires Terrain Bio

Taconic Biosciences Acquires TransCure bioServices

January 20, 2026

Biotechnology

Taconic Biosciences has acquired TransCure bioServices SAS to create an integrated global translational research platform combining Taconic's genetically engineered and humanized mouse models with TransCure's preclinical in vivo services. The deal expands Taconic's capabilities across oncology, immunology, infectious disease, and advanced modalities while preserving TransCure's brand and operational structure to ensure continuity for employees and clients.

Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics

January 9, 2026

Biotechnology

Acuitas Therapeutics has acquired a majority stake in RNA Technologies & Therapeutics (RNA T&T), deepening a long-standing collaboration to integrate RNA payload design and LNP delivery capabilities. The investment will support RNA T&T's growth—expanding its algorithmic RNA-sequence optimization platform and small-batch GMP production—while both companies continue to operate independently and offer streamlined capabilities to partners.

Cushing Terrell Acquires Eclipse Engineering

July 1, 2024

Engineering Services

Multidisciplinary design firm Cushing Terrell has acquired structural engineering firm Eclipse Engineering, bringing Eclipse's regional offices and specialty structural capabilities into Cushing Terrell's platform. Eclipse's leadership will join Cushing Terrell's structural engineering practice to expand capabilities in mass timber, tilt‑up concrete, seismic retrofits, and other specialty services.

ElevateBio Acquires Life Edit Therapeutics from AgBiome Delta

October 27, 2021

Biotechnology

ElevateBio acquired all of AgBiome Delta, LLC's shares of Life Edit Therapeutics, bringing Life Edit's RNA-guided nuclease and base editor technologies into ElevateBio's cell and gene therapy technology platform. The acquisition expands ElevateBio's genome engineering capabilities to support its in vivo gene therapy pipeline (initial focus on neurologic conditions) and to offer enhanced gene-editing tools and manufacturing access to industry partners.

Bionano Genomics Acquires BioDiscovery

October 12, 2021

Software

Bionano Genomics agreed to acquire BioDiscovery, a provider of NxClinical genomics analysis software, in a deal worth up to $100 million in cash and equity. The acquisition will integrate BioDiscovery's platform-agnostic analysis and reporting tools with Bionano's optical genome mapping technology to accelerate variant analysis and broaden Bionano's market reach; BioDiscovery founder Soheil Shams will join Bionano as Chief Informatics Officer.

BioIVT Acquires ZenBio

August 21, 2024

Healthcare Services

BioIVT has acquired ZenBio, a Durham-based provider of advanced cell products and biospecimen services, to expand its skin-based expertise, primary cell and exosome isolation capabilities, and blood product offerings for pharmaceutical and cosmetics research. The deal strengthens BioIVT's service portfolio and complements recent integrations to accelerate support for drug discovery and cosmeceutical development; financial terms were not disclosed.